TGFBR2 and lung adenocarcinoma: To investigate the pre-clinical utility of aurora kinase inhibitors and to evaluate its efficacy in suppressing invasive lung adenocarcinoma, we treated the transgenic invasive LUAD mouse model of KrasG12D mutation and inducible Tgfbr2 deletion with AMG900.